H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
Go back to H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)| (NASDAQ: URGN) | Delayed: 41.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.09 | 52 Week High | $ | |||
| Open | $41.09 | 52 Week Low | $ | |||
| Day High | $41.09 | P/E | N/A | |||
| Day Low | $41.09 | EPS | $ | |||
| Volume | 3 | |||||

